2022 Regulatory Activity in the Pharmaceutical Sector of India

The Indian Pharmacopoeia Commission has published the Indian Pharmacopoeia 2022 to supplement the current Indian Pharmacopoeia – the book of standards under the Drugs and Cosmetics Act,1940. IP 2022 is likely to be effective from December 1, 2022.

Related Keywords

India ,Burkholderia Cepacia ,National Pharmaceutical Pricing Authority ,Central Licensing Authority ,Indian Pharmacopoeia Commission ,Ministry Of Consumer Affairs ,Health Ministry ,Indian Pharmacopoeia ,Cosmetics Act ,Standard Quality ,Consumer Affairs ,Legal Metrology ,Packaged Commodities ,Amendment Rules ,Frequently Asked Questions ,Legal Metrology Act ,Maximum Retail Price ,Cosmetics Rules ,Quick Response ,New Drugs ,Clinical Trials Rules ,State Licensing Authorities ,Drug Technical Advisory Board ,Prices Control ,Legal ,Government ,Business ,Drugs And Cosmetics Act ,Cup 2022 ,World ,Cdsco ,Hemohfw ,